Three more Legionnaires’ cases reported at Mount Carmel Grove City Hospital

One person who contracted Legionnaires’ has died


Three more cases of Legionnaires’ disease have been confirmed at Mount Carmel Grove City Hospital, in Grove City, Ohio, raising the total to 10 cases, according to an article on the Columbus Dispatch website.

One person who contracted Legionnaires’ has died, according to Franklin County Public Health.

Mount Carmel Health Systems initially announced Friday that there were seven victims of the disease at the new $361 million hospital that opened April 28. 

It is believed that patients were exposed sometime between April 27 and May 24.

Read the article.



June 10, 2019


Topic Area: Infection Control


Recent Posts

Partnering on Personnel: Strategies for Success

Environmental services in healthcare have special staffing circumstances. They must meet stringent compliance standards and maintain accreditations.


Kaiser Permanente Opens First Two Medical Offices in Northern Nevada

These are part of its joint venture with Renown Health.


Acadia Healthcare Reports Data Breach

This incident did not disrupt Acadia’s operations or its ability to care for patients.


Site Selection Mistakes: What Not To Do

Healthcare providers that treat site selection as a strategic decision, not a simple real estate deal, will be positioned for long-term success.


High-Performance EFCO Systems Shape MUSC's New Black River Medical Center

Case study: A sweeping curved-glass entrance, impact-resistant envelope and energy-efficient fenestration support a sustainable, resilient design for one of South Carolina’s newest rural hospitals.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.